课题基金 / 基金详情

PharmaLink Conference

PharmaLink Conference
PharmaLink会议
批准号:
10828206
负责人:
Steven Mandernach
金额:
$5.0万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2028-06-30
关键词:

项目摘要

项目成果

Steven Mandernach的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary The key objectives of the PharmaLink Conference are:  Open collaboration and engagement with FDA and industry to discuss pharmaceutical challenges and opportunities.  Identify innovative solutions for rising issues in the pharmaceutical industry and across healthcare. AFDO proposes the PhamaLink Conference plan to follow this format:  During years 2023-2024 there will be an in-person conference with presentations and facilitated discussions on identifying and building innovative and collaborative solutions to be used in the pharmaceutical industry to advance patient care. During each conference, a group of 130+ Pharmaceutical leaders from all areas of the industry will come together to lead innovation around the issues surfaced during the collaborative opportunities between industry and regulators.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Artificial Intelligence (AI) Summit
Artificial Intelligence (AI) Summit
Retail Food Safety Regulatory Association Collaboration
Retail Food Safety Regulatory Association Collaboration
海外基金